Venture Capital Firm | Contact, Portfolio & Investment Focus
unknown
Pivotal bioVenture Partners CNS Fund I, L.P. focuses on unknown investments, targeting companies at this specific growth phase.
Check size information is not publicly disclosed. Reach out directly to discuss investment amounts.
Richard Coles; Vincent Sai Sing Cheung; Peter Bisgaard
This region offers unique opportunities for startups and investors with growing venture capital activity.
Visit Pivotal bioVenture Partners CNS Fund I, L.P.'s official website to find their contact information and pitch submission process.
Pivotal bioVenture Partners CNS Fund I, L.P.'s typical check size is not publicly disclosed. Contact the firm directly for investment range details.
Pivotal bioVenture Partners CNS Fund I, L.P. focuses on unknown investments. Companies at this stage typically have established product-market fit and are ready to scale.
Pivotal bioVenture Partners CNS Fund I, L.P.'s current deployment status may vary. Check their recent announcements or contact them directly.
Pivotal bioVenture Partners CNS Fund I, L.P. is headquartered in WILMINGTON, DE. They may consider investments from startups outside their immediate geography.
Yes, Pivotal bioVenture Partners CNS Fund I, L.P. accepts pitch submissions through their website. Visit their site to find their submission form or founder portal.
Andromeda 2025 LP
unknown
Crucible Capital Fund I, L.P.
seed
BITKRAFT C1ST, LLC
unknown
Norland Dancerace, LP
seed
FrissOn Capital Fund I, LP
seed
Chalo Ventures, L.P.
seed
Data Sources: SEC EDGAR filings, company disclosures, and verified public records.
Last updated: Recently